ロード中...

Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele

Chronic myeloid leukemia in chronic phase (CML-CP) cells that harbor oncogenic BCR-ABL1 and normal ABL1 allele often become resistant to the ABL1 kinase inhibitor imatinib. Here we report that loss of the remaining normal ABL1 allele in these tumors, which results from cryptic interstitial deletion...

詳細記述

保存先:
書誌詳細
主要な著者: Virgili, Anna, Koptyra, Mateusz, Dasgupta, Yashodhara, Glodkowska-Mrowka, Eliza, Stoklosa, Tomasz, Nacheva, Elisabeth P., Skorski, Tomasz
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156347/
https://ncbi.nlm.nih.gov/pubmed/21693657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0068
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!